These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2474905)

  • 21. Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junín Viruses.
    Borenstein-Katz A; Shulman A; Hamawi H; Leitner O; Diskin R
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible approaches to a vaccine against Lassa fever.
    Clegg JC
    Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128
    [No Abstract]   [Full Text] [Related]  

  • 23. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.
    Jahrling PB; Peters CJ
    Infect Immun; 1984 May; 44(2):528-33. PubMed ID: 6715049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus].
    Ignat'ev GM; Kaliberov SA; Pereboeva LA; Tverdokhlebov AB; Kras'ko AG; Godneva AT
    Vopr Virusol; 1994; 39(6):257-60. PubMed ID: 7536373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the immune response elicited by infectious and inactivated foot-and-mouth disease virus in mice.
    Piatti PG; Berinstein A; Lopez OJ; Borca MV; Fernandez F; Schudel AA; Sadir AM
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1691-4. PubMed ID: 1649903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
    Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
    Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of protective properties of attenuated strain of Argentinian hemorrhagic fever].
    Ignat'ev GM; Blinov VM; Romanowski V
    Vopr Virusol; 1996; 41(4):158-61. PubMed ID: 8999669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus.
    Walker CM; Rawls WE; Rosenthal KL
    J Immunol; 1984 Jan; 132(1):469-74. PubMed ID: 6317748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological survey for the detection of antibodies to lassa virus in India.
    Rodrigues FM; Gupta NP; Pinto BD
    J Indian Med Assoc; 1978 Jan; 70(2):25-8. PubMed ID: 659905
    [No Abstract]   [Full Text] [Related]  

  • 30. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of monoclonal antibodies against Lassa virus].
    Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunologic indicators in vaccinated mice with Machupo virus infection].
    Patrusheva IV; Kaliberov SA; Kashentseva EA; Ignat'ev GM
    Vopr Virusol; 1997; 42(3):137-40. PubMed ID: 9297347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus].
    Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS
    Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
    Youn HJ; Ko SY; Lee KA; Ko HJ; Lee YS; Fujihashi K; Boyaka PN; Kim SH; Horimoto T; Kweon MN; Kang CY
    Vaccine; 2007 Jul; 25(28):5189-98. PubMed ID: 17548137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria.
    Fabiyi A; Tomori O; Pinneo P
    Niger Med J; 1979 Jan; 9(1):23-5. PubMed ID: 463337
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immune response in vaccinated and non-vaccinated mice infected with tick-borne encephalitis virus].
    Ignat'ev GM; Bukin EK; Otrashevskaia EV; Rasshchepkina MN; Vorob'eva MS
    Vopr Virusol; 2006; 51(5):22-7. PubMed ID: 17087061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
    Jahrling PB
    J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.
    Goldwasser RA; Elliott LH; Johnson KM
    J Clin Microbiol; 1980 Jun; 11(6):593-9. PubMed ID: 7000810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary biology of a Lassa virus complex.
    Gonzalez JP; Georges AJ; Kiley MP; Meunier DM; Peters CJ; McCormick JB
    Med Microbiol Immunol; 1986; 175(2-3):157-9. PubMed ID: 3724662
    [No Abstract]   [Full Text] [Related]  

  • 40. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.
    Hufert FT; Lüdke W; Schmitz H
    Arch Virol; 1989; 106(3-4):201-12. PubMed ID: 2476109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.